Neonatal Warming to Prevent Hypothermia
Primary Purpose
Hypothermia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Neonatal warming mattress
Sterile polyethylene wrap
Sponsored by
About this trial
This is an interventional prevention trial for Hypothermia
Eligibility Criteria
Inclusion Criteria:
- Patients who have non-emergent cesarean deliveries (defined as at least 2 hours prior to planned cesarean)
- Gestational age between 32 weeks and 0 days and 36 weeks and 6 days determined per usual clinical parameters
Exclusion Criteria:
- Fetal anomalies or death
- Maternal diabetes
- Neonates with blistering skin conditions
- Reversed end diastolic umbilical artery flow
- Placental abruption
- Chorioamnionitis
- Monochorionic multifetal pregnancies
- Inability to provide consent
- Provider perception that patient is in significant pain and provider perceived contraindications to delayed cord clamping.
Sites / Locations
- University ofOklahoma Health Sciences Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention group
Control group
Arm Description
In the intervention group, the infant will be placed on the thermal mattress, then wrapped.
In the non-intervention group, the infant will be delivered onto the sterile field as per standard of care.
Outcomes
Primary Outcome Measures
Difference in temperature
Difference in temperature at time of arrival to the warmer
Secondary Outcome Measures
Temperature at completion of resuscitation
Need for NICU admission
Temperature upon leaving the delivery room
Temperature upon admission to the NICU (if required)
Hypoglycemia (less than 30mg/dL in the first 24 hours)
Highest bilirubin level
Respiratory support in the form of intubation or continuous positive airway pressure (if applicable)
Pulmonary hemorrhage (if applicable)
Hyperthermia (>37.5 degrees C) (if applicable)
Number of days in the NICU (if applicable)
Composite neonatal morbidity (if applicable)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04827394
Brief Title
Neonatal Warming to Prevent Hypothermia
Official Title
Preventing Hypothermia in Moderate and Late Preterm Neonates - a Pilot Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
December 1, 2020 (Actual)
Primary Completion Date
February 21, 2023 (Actual)
Study Completion Date
February 21, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Oklahoma
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Researchers are proposing a pilot randomized controlled trial evaluating the benefit of immediately warming preterm babies using a warming mattress and a plastic wrap, while delaying clamping the umbilical cord at the time of c-section in babies born between 32 and 36 weeks to determine if it reduces the risk of hypothermia.
Detailed Description
The trial will be advertised and introduced to patients admitted to the OU Children's Hospital labor and delivery or antepartum units by research nurses. Interested participants will be consented. Researchers are choosing to only include patients undergoing non-emergent cesarean in order to improve their ability to control parameters such as room temperature and labor-related clinical or subclinical maternal infection, which are known confounders. Further, they are limiting their investigation to fetuses 32-36 weeks gestation, since this population represents the largest preterm delivery population. Recruitment and randomization will be stratified by gestational age with an aim to enroll at least 44 pregnancies at 32-34 weeks and 6 days and 20 pregnancies between 35-36 weeks and 6 days. Last, it is impossible to recruit patients outside of the inpatient setting for a study investigating preterm delivery, as such deliveries are rarely predictable in the outpatient setting. There will only be one site for this study, the OU Children's Hospital labor and delivery and antepartum units.
The proposed study is a pragmatic randomized controlled pilot trial of neonatal warming techniques with participants allocated in a 1:1 ratio using a random block allocation table using blocks of size 4 and 6 that are stratified by gestational age ranges of 35-36 weeks and 6 days and 32-34 weeks and 6 days. Since there cannot be a placebo intervention, neither the patient nor the neonatal team will be blinded to the group assignment. The group assignments will be made and coded by a third party at the time of randomization. Patients will be randomized to their respective groups immediately prior to surgery.
The surgical technician will be provided with the necessary neonatal wraps and mattresses in a sterile fashion, and they will ensure these are available on the surgical field once the cesarean has begun. In the intervention group, the thermal mattress will be activated immediately prior to hysterotomy and placed on the sterile field with delivery of the infant directly onto the mattress. The infant will be dried, stimulated and bulb suctioned as deemed necessary per standard of care followed by wrapping. In the non-intervention group, the infant will be delivered onto the sterile field, dried and suctioned as deemed necessary per OU standard. Cord clamping will be delayed for 60 seconds in all infants under the supervision of both the obstetrician and the neonatal resuscitation team. If either team believes delayed cord clamping is no longer considered safe, as is usual protocol, the cord will be clamped and cut and the baby will be handed off to the neonatology team. After the infant is handed to the neonatology team along with all group assignment specific materials (neonatal wrap and thermal mattress, if in the intervention group), neonatal temperature will be assessed immediately upon arrival to the resuscitation warmer using a digital thermometer placed in the axillary space. Infant temperature will be recorded at 1) arrival to the warmer, 2) after the neonatologist deems that in-room resuscitation is complete and 3) at admission to the Neonatal Intensive Care Unit (NICU), Mother Baby Unit (MBU) or Post-Anesthesia Care Unit (PACU) depending on the baby's needs; determined by the resuscitating physicians. These measurements will be recorded by research nurses in a data collection sheet. Further, the research nurse will record the time from delivery to the time it takes for the infant to arrive at the warmer. Upon arrival at the warmer, the mattress and wrap will be removed as neonatal evaluation takes place.
As immediate neonatal temperature is not generally discussed with patients unless there is an issue such as concern for infection, neonatal temperature will not be routinely discussed with all participants. Only if there is concern for neonatal infection or if there is hyperthermia (>37.5 degrees C) will the study results be discussed with the patient.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypothermia
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
1:1 using a block randomization scheme stratified by gestational age
Masking
None (Open Label)
Allocation
Randomized
Enrollment
51 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention group
Arm Type
Experimental
Arm Description
In the intervention group, the infant will be placed on the thermal mattress, then wrapped.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
In the non-intervention group, the infant will be delivered onto the sterile field as per standard of care.
Intervention Type
Device
Intervention Name(s)
Neonatal warming mattress
Intervention Description
Babies will be warmed with a standard neonatal transport warming mattress immediately after birth.
Intervention Type
Device
Intervention Name(s)
Sterile polyethylene wrap
Intervention Description
Babies will be wrapped in a sterile polyethylene wrap prior to arrival at the warmer.
Primary Outcome Measure Information:
Title
Difference in temperature
Description
Difference in temperature at time of arrival to the warmer
Time Frame
3 minutes
Secondary Outcome Measure Information:
Title
Temperature at completion of resuscitation
Time Frame
3 minutes
Title
Need for NICU admission
Time Frame
24 hours
Title
Temperature upon leaving the delivery room
Time Frame
24 hours
Title
Temperature upon admission to the NICU (if required)
Time Frame
24 hours
Title
Hypoglycemia (less than 30mg/dL in the first 24 hours)
Time Frame
24 hours
Title
Highest bilirubin level
Time Frame
Through hospital discharge up to 3 months
Title
Respiratory support in the form of intubation or continuous positive airway pressure (if applicable)
Time Frame
Through hospital discharge up to 3 months
Title
Pulmonary hemorrhage (if applicable)
Time Frame
Through hospital discharge up to 3 months
Title
Hyperthermia (>37.5 degrees C) (if applicable)
Time Frame
Through hospital discharge up to 3 months
Title
Number of days in the NICU (if applicable)
Time Frame
Through hospital discharge up to 3 months
Title
Composite neonatal morbidity (if applicable)
Time Frame
Through hospital discharge up to 3 months
10. Eligibility
Sex
Female
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who have non-emergent cesarean deliveries (defined as at least 2 hours prior to planned cesarean)
Gestational age between 32 weeks and 0 days and 36 weeks and 6 days determined per usual clinical parameters
Exclusion Criteria:
Fetal anomalies or death
Maternal diabetes
Neonates with blistering skin conditions
Reversed end diastolic umbilical artery flow
Placental abruption
Chorioamnionitis
Monochorionic multifetal pregnancies
Inability to provide consent
Provider perception that patient is in significant pain and provider perceived contraindications to delayed cord clamping.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Birju Shah, MD
Organizational Affiliation
University of Oklahoma HSC
Official's Role
Principal Investigator
Facility Information:
Facility Name
University ofOklahoma Health Sciences Center
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73104
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
No plans to share data
Learn more about this trial
Neonatal Warming to Prevent Hypothermia
We'll reach out to this number within 24 hrs